National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9a. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N % California Enteritidis 12 21.8 1 8.3 0 0 0 0 0 0 Typhimurium 12 21.8 8 66.7 7 58.3 5 41.7 0 0 Heidelberg 7 12.7 3 42.8 2 28.6 0 0 0 0 Saint Paul 3 5.4 0 0 0 0 0 0 0 0 Hadar 2 3.6 2 100.0 1 50.0 0 0 0 0 Javiana 2 3.6 0 0 0 0 0 0 0 0 Newport 2 3.6 1 50.0 1 50.0 1 50.0 1 50.0

2 Thompson 2 3.6 0 0 0 0 0 0 0 0

6 Other 13 23.6 1 7.7 1 7.7 0 0 0 0 Total 55 100.0 16 29.1 12 21.8 6 10.1 1 1.8 Colorado Enteritidis 20 30.3 3 15.0 1 5.0 0 0 0 0 Typhimurium 17 25.7 11 64.7 10 58.8 6 35.3 0 0 Heidelberg 5 7.6 3 60.0 3 60.0 0 0 0 0 Montevideo 5 7.6 0 0 0 0 0 0 0 0 Newport 5 7.6 2 40.0 2 40.0 2 40.0 2 40.0 Other 14 21.2 6 42.8 5 35.7 0 0 0 0 Total 66 100.0 25 37.8 21 31.8 8 12.1 2 3.0 *Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9b. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

Connecticut Enteritidis 13 27.7 1 7.7 1 7.7 0 0 0 0

Typhimurium 10 21.3 5 50.0 5 50.0 5 50.0 1 10.0

Muenchen 4 8.5 0 0 0 0 0 0 0 0

Heidelberg 3 6.4 1 33.3 0 0 0 0 0 0

Newport 3 6.4 2 66.7 2 66.7 2 66.7 2 66.7

Virchow 3 6.4 1 33.3 0 0 0 0 0 0

Other 11 23.4 3 27.3 1 9.1 1 9.1 0 0

2 7 Total 47 100.0 13 27.6 9 19.1 8 17.0 3 6.4

Florida Javiana 14 23.3 0 0 0 0 0 0 0 0

Newport 13 21.7 0 0 0 0 0 0 0 0

Typhimurium 12 20.0 6 50.0 5 41.7 3 25.0 0 0

Flint 4 6.7 0 0 0 0 0 0 0 0

Enteritidis 2 3.3 1 50.0 0 0 0 0 0 0

Manhattan 2 3.3 0 0 0 0 0 0 0 0

Montevideo 2 3.3 0 0 0 0 0 0 0 0

Oranienburg 2 3.3 0 0 0 0 0 0 0 0

Other 9 15.0 1 11.1 1 11.1 1 11.1 0 0

Total 60 100.0 8 13.3 6 10.0 4 6.7 0 0

*Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9c. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N % Georgia Typhimurium 45 24.2 22 48.9 19 42.2 13 28.9 0 0 Newport 27 14.5 1 3.7 1 3.7 1 3.7 1 3.7 Javiana 17 9.1 0 0 0 0 0 0 0 0 Enteritidis 15 8.1 2 13.3 1 6.7 0 0 0 0 Infantis 9 4.8 1 11.1 1 11.1 0 0 0 0 Other 67 36.0 5 7.5 5 7.5 1 1.5 1 1.5

2

8 Not Serotyped 6 3.2 1 16.7 1 16.7 0 0 0 0 Total 186 100.0 32 17.2 28 15.0 15 8.1 2 1.1 Kansas Typhimurium 13 36.1 3 23.1 3 23.1 3 23.1 2 15.4 Newport 6 16.7 4 66.7 4 66.7 4 66.7 4 66.7 Enteritidis 3 8.3 0 0 0 0 0 0 0 0 Agona 2 5.5 1 50.0 1 50.0 1 50.0 1 50.0 Other 8 22.2 0 0 0 0 0 0 0 0 Not Serotyped 4 11.1 1 25.0 1 25.0 1 25.0 0 0 Total 36 100.0 9 25.0 9 25.0 9 25.0 7 19.4 *Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole

National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9d. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

Los Angeles Enteritidis 25 22.5 0 0 0 0 0 0 0 0 County Typhimurium 20 18.0 9 45.0 9 45.0 6 30.0 1 5.0

Newport 9 8.1 5 55.5 3 33.3 3 33.3 3 33.3

Thompson 5 4.5 0 0 0 0 0 0 0 0

Berta 4 3.6 4 100.0 3 75.0 0 0 0 0

Montevideo 4 3.6 1 25.0 1 25.0 0 0 0 0

Oranienburg 4 3.6 0 0 0 0 0 0 0 0

2 Other 37 33.3 10 27.0 7 18.9 3 8.1 1 2.7

9 Not Serotyped 3 2.7 3 100.0 3 100.0 2 66.7 0 0

Total 111 100.0 32 28.8 26 23.4 14 12.6 5 4.5

Maryland Enteritidis 19 34.5 2 10.5 1 5.3 0 0 0 0

Typhimurium 8 14.5 5 62.5 4 50.0 4 50.0 0 0

Heidelberg 3 5.4 1 33.3 1 33.3 0 0 0 0

Javiana 3 5.4 0 0 0 0 0 0 0 0

Newport 3 5.4 0 0 0 0 0 0 0 0

Other 16 29.1 4 25.0 3 18.7 0 0 0 0

Not Serotyped 3 5.4 0 0 0 0 0 0 0 0

Total 55 100.0 12 21.8 9 16.4 4 7.3 0 0

*Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9e. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

Massachusetts Enteritidis 30 24.6 1 3.3 0 0 0 0 0 0

Typhimurium 26 21.3 10 38.5 10 38.5 9 34.6 2 7.7

Heidelberg 11 9.0 4 36.4 2 18.2 0 0 0 0

Newport 9 7.4 4 44.4 4 44.4 4 44.4 4 44.4

Thompson 8 6.6 0 0 0 0 0 0 0 0

Other 36 29.5 11 30.5 7 19.4 3 8.3 0 0

Not Serotyped 2 1.6 0 0 0 0 0 0 0 0

3

0 Total 122 100.0 30 24.6 23 18.8 16 13.1 6 4.9

Minnesota Typhimurium 23 39.0 7 30.4 6 26.1 5 21.7 0 0

Enteritidis 11 18.6 1 9.1 0 0 0 0 0 0

Newport 4 6.8 2 50.0 2 50.0 2 50.0 1 25.0

Agona 2 3.4 1 50.0 1 50.0 0 0 0 0

Java 2 3.4 0 0 0 0 0 0 0 0

Muenchen 2 3.4 0 0 0 0 0 0 0 0

Senftenberg 2 3.4 0 0 0 0 0 0 0 0

Thompson 2 3.4 0 0 0 0 0 0 0 0

Other 9 15.2 2 22.2 2 22.2 0 0 0 0

Not Serotyped 2 3.4 0 0 0 0 0 0 0 0

Total 59 100.0 13 22.0 11 18.6 7 12.1 1 1.7 *Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9f. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

New Jersey Enteritidis 47 40.5 4 8.5 0 0 0 0 0 0

Typhimurium 28 24.1 16 57.1 16 57.1 12 42.8 0 0

Newport 6 5.2 1 16.7 1 16.7 1 16.7 1 16.7

Heidelberg 5 4.3 3 60.0 3 60.0 1 20.0 0 0

Berta 2 1.7 1 50.0 1 50.0 0 0 0 0

Litchfield 2 1.7 0 0 0 0 0 0 0 0

3

1 Oranienburg 2 1.7 0 0 0 0 0 0 0 0

Poona 2 1.7 0 0 0 0 0 0 0 0

Other 17 14.6 4 23.5 2 11.8 1 5.9 0 0

Not Serotyped 5 4.3 3 60.0 3 60.0 0 0 0 0

Total 116 100.0 32 27.6 26 22.4 13 11.2 1 0.9

*Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9g. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

New York Enteritidis 60 45.8 16 26.7 4 6.7 0 0 0 0 City Typhimurium 21 16.0 15 71.4 15 71.4 13 61.9 0 0

Heidelberg 6 4.6 2 33.3 2 33.3 0 0 0 0

Infantis 4 3.0 0 0 0 0 0 0 0 0

Saint Paul 4 3.0 1 25.0 1 25.0 0 0 0 0

Thompson 4 3.0 2 50.0 1 25.0 0 0 0 0

3

2 Other 29 22.1 5 17.2 4 13.8 0 0 0 0

Not Serotyped 3 2.3 1 33.3 1 33.3 1 33.3 0 0

Total 131 100.0 42 32.1 28 21.4 14 10.7 0 0

New York Enteritidis 34 27.0 3 8.8 1 2.9 0 0 0 0 State Typhimurium 25 19.8 8 32.0 7 28.0 6 24.0 0 0

Heidelberg 9 7.1 3 33.3 1 11.1 1 11.1 0 0

Hadar 6 4.8 6 100.0 5 83.3 0 0 0 0

Infantis 5 4.0 1 20.0 1 20.0 1 20.0 0 0

Other 39 30.9 7 17.9 5 12.8 3 7.7 2 5.1

Not Serotyped 8 6.3 2 25.0 2 25.0 0 0 0 0

Total 126 100.0 30 23.8 22 17.5 11 8.7 2 1.6

*Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole

National Antimicrobial Resistance Monitoring System For Enteric Bacteria Table 9h. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

Oregon Enteritidis 7 20.6 0 0 0 0 0 0 0 0

Typhimurium 5 14.7 3 60.0 3 60.0 2 40.0 0 0

Montevideo 3 8.8 0 0 0 0 0 0 0 0

Newport 3 8.8 0 0 0 0 0 0 0 0

Saint Paul 3 8.8 1 33.3 1 33.3 0 0 0 0

Other 12 35.3 5 41.7 4 33.3 0 0 0 0

3

3 Not Serotyped 1 2.9 0 0 0 0 0 0 0 0

Total 34 100.0 9 26.5 8 23.5 2 5.9 0 0

Tennessee Newport 20 26.3 5 25.0 5 25.0 5 25.0 5 25.0

Typhimurium 11 14.5 7 63.6 7 63.6 7 63.6 0 0

Heidelberg 8 10.5 4 50.0 3 37.5 1 12.5 1 12.5

Enteritidis 6 7.9 0 0 0 0 0 0 0 0

Other 23 30.3 3 13.0 2 8.7 0 0 0 0

Not Serotyped 8 10.5 1 12.5 1 12.5 0 0 0 0

Total 76 100.0 20 26.3 18 23.7 13 17.1 6 7.9

*Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole National Antimicrobial Resistance Monitoring System For Enteric Bacteria

Table 9i. Frequency of multidrug* resistance among the most common non-Typhi Salmonella serotypes in each state, 2000

Site Most Common Total Number resistant to Number resistant to Number resistant to Number resistant to Serotypes > 1 antimicrobial > 2 antimicrobials > 5 antimicrobials > 8 antimicrobials N % N % N % N % N %

Washington Typhimurium 23 30.7 17 73.9 16 69.6 12 52.2 3 13.0

Enteritidis 11 14.7 0 0 0 0 0 0 0 0

Heidelberg 7 9.3 1 14.3 1 14.3 0 0 0 0

Newport 6 8.0 1 16.7 1 16.7 1 16.7 1 16.7

Saint Paul 4 5.3 1 25.0 0 0 0 0 0 0

Other 23 30.7 5 21.7 5 21.7 2 8.7 0 0

Not Serotyped 1 1.3 1 100.0 1 100.0 1 100.0 0 0

3

4 Total 75 100.0 26 34.7 24 32.0 16 21.3 4 5.3

West Virginia Enteritidis 4 17.4 0 0 0 0 0 0 0 0 Typhimurium 4 17.4 1 25.0 1 25.0 1 25.0 0 0 Heidelberg 3 13.0 1 33.3 1 33.3 1 33.3 0 0 Newport 3 13.0 1 33.3 1 33.3 1 33.3 1 33.3 Hadar 2 8.7 1 50.0 1 50.0 0 0 0 0 Other 7 30.4 0 0 0 0 0 0 0 0 Total 23 100.0 4 17.4 4 17.4 3 13.0 1 4.3

*Multidrug resistant to antimicrobial agents tested, 1996-2000: amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, trimethoprim-sulfamethoxazole